NDC 45802-627 – Budesonide
Budesonide 2 mg/1 · Aerosol, Foam · Rectal
Product NDC45802-627
Product details
- Brand name
- Budesonide
- Generic name
- Budesonide
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- Aerosol, Foam
- Route
- Rectal
- Marketing category
- ANDA · ANDA215328
- Marketed since
- April 17, 2023
- Listing expires
- December 31, 2026
- Pharmacologic class
- Corticosteroid
Active ingredients
- Budesonide 2 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 45802-627-86 | 2 CANISTER in 1 CARTON (45802-627-86) / 1 AEROSOL, FOAM in 1 CANISTER (45802-627-01) | Apr 17, 2023 |
Other Budesonide products
- 68682-658 Budesonide 2 mg/1 · Aerosol, Foam · Oceanside Pharmaceuticals
- 50090-6590 Budesonide .25 mg/2mL · Suspension · A-S Medication Solutions
- 50090-1467 Budesonide .25 mg/2mL · Suspension · A-S Medication Solutions
- 50090-6586 Budesonide .5 mg/2mL · Suspension · A-S Medication Solutions
- 50090-7173 Budesonide .25 mg/2mL · Inhalant · A-S Medication Solutions
- 0591-2510 Budesonide 9 mg/1 · Tablet, Film Coated, Extended Release · Actavis Pharma, Inc.
- 60687-596 Budesonide 3 mg/1 · Capsule, Coated Pellets · American Health Packaging
- 60687-889 Budesonide .25 mg/2mL · Suspension · American Health Packaging
- 65162-778 Budesonide 3 mg/1 · Capsule, Delayed Release · Amneal Pharmaceuticals LLC
- 53746-778 Budesonide 3 mg/1 · Capsule, Delayed Release · Amneal Pharmaceuticals of New York LLC
- 60505-6129 Budesonide 32 ug/1 · Spray, Metered · Apotex Corp.
- 59651-585 Budesonide .5 mg/2mL · Suspension · Aurobindo Pharma Limited